Foundry DelEqu Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1CRM | SALESFORCE INC | Technology | $139.86B | 9.53% |
2FTNT | FORTINET INC | Technology | $118.40B | 8.07% |
3HLT | HILTON WORLDWIDE HOLDINGS INC | Consumer Cyclical | $73.15B | 4.98% |
4TDG | TRANSDIGM GROUP INC | Industrials | $67.93B | 4.63% |
5MSCI | MSCI INC | Financial Services | $45.77B | 3.12% |
6CMG | CHIPOTLE MEXICAN GRILL INC | Consumer Cyclical | $44.18B | 3.01% |
7RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 2.70% |
8WDAY | WORKDAY INC | Technology | $35.76B | 2.44% |
9ZTS | ZOETIS INC | Healthcare | $32.10B | 2.19% |
10FICO | FAIR ISAAC CORP | Technology | $29.15B | 1.99% |
11TPR | TAPESTRY INC | Consumer Cyclical | $28.58B | 1.95% |
12ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 1.82% |
13VRSK | VERISK ANALYTICS INC | Industrials | $26.29B | 1.79% |
14VRSN | VERISIGN INC | Technology | $25.27B | 1.72% |
15MRNA | MODERNA INC | Healthcare | $24.53B | 1.67% |
16TEAM | ATLASSIAN CORP | Technology | $23.67B | 1.61% |
17UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 1.55% |
18RIVN | RIVIAN AUTOMOTIVE INC | Consumer Cyclical | $22.00B | 1.50% |
19IP | INTERNATIONAL PAPER CO | Consumer Cyclical | $19.89B | 1.35% |
20FTV | FORTIVE CORP | Technology | $18.83B | 1.28% |
21DD | DUPONT DE NEMOURS INC | Basic Materials | $18.49B | 1.26% |
22BBIO | BRIDGEBIO PHARMA INC | Healthcare | $15.94B | 1.09% |
23CSL | CARLISLE COMPANIES INC | Basic Materials | $13.98B | 0.95% |
24IVZ | INVESCO LTD | Financial Services | $13.13B | 0.89% |
25PINS | PINTEREST INC | Communication Services | $13.00B | 0.89% |
26MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | $12.76B | 0.87% |
27COKE | COCA-COLA CONSOLIDATED INC | Consumer Defensive | $12.03B | 0.82% |
28OC | OWENS CORNING | Basic Materials | $11.59B | 0.79% |
29CART | INSTACART (MAPLEBEAR INC) | Consumer Cyclical | $10.77B | 0.73% |
30CYTK | CYTOKINETICS INC | Healthcare | $9.98B | 0.68% |
31WLK | WESTLAKE CORP | Basic Materials | $9.95B | 0.68% |
32PSKY | PARAMOUNT SKYDANCE CORP | Communication Services | $9.79B | 0.67% |
33MANH | MANHATTAN ASSOCIATES INC | Technology | $9.66B | 0.66% |
34IT | GARTNER INC | Technology | $9.39B | 0.64% |
35HALO | HALOZYME THERAPEUTICS INC | Healthcare | $9.23B | 0.63% |
36GKOS | GLAUKOS CORP | Healthcare | $9.21B | 0.63% |
37LB | LANDBRIDGE CO LLC | Energy | $8.89B | 0.61% |
38IBRX | IMMUNITYBIO INC | Healthcare | $8.04B | 0.55% |
39RAL | RALLIANT CORP | Technology | $7.85B | 0.53% |
40HXL | HEXCEL CORP | Industrials | $7.83B | 0.53% |
41MBLY | MOBILEYE GLOBAL INC | Consumer Cyclical | $7.76B | 0.53% |
42TAP | MOLSON COORS BEVERAGE CO | Consumer Defensive | $7.28B | 0.50% |
43DBX | DROPBOX INC | Technology | $7.14B | 0.49% |
44PAYC | PAYCOM SOFTWARE INC | Technology | $7.05B | 0.48% |
45RIOT | RIOT PLATFORMS INC | Financial Services | $6.91B | 0.47% |
46FLR | FLUOR CORP | Industrials | $6.86B | 0.47% |
47CAG | CONAGRA BRANDS INC | Consumer Defensive | $6.83B | 0.47% |
48CROX | CROCS INC | Consumer Cyclical | $6.81B | 0.46% |
49CHE | CHEMED CORP | Healthcare | $6.77B | 0.46% |
50CORZ | CORE SCIENTIFIC INC | Technology | $6.66B | 0.45% |
51MORN | MORNINGSTAR INC | Financial Services | $6.56B | 0.45% |
52CVLT | COMMVAULT SYSTEMS INC | Technology | $6.10B | 0.42% |
53MIDD | MIDDLEBY CORP | Industrials | $6.02B | 0.41% |
54TFX | TELEFLEX INC | Healthcare | $5.96B | 0.41% |
55RIG | TRANSOCEAN LTD | Energy | $5.74B | 0.39% |
56STEP | STEPSTONE GROUP INC | Financial Services | $5.20B | 0.35% |
57CRC | CALIFORNIA RESOURCES CORP | Energy | $4.69B | 0.32% |
58LBRDA | LIBERTY BROADBAND CORP | Communication Services | $4.43B | 0.30% |
59TENB | TENABLE HOLDINGS INC | Technology | $4.40B | 0.30% |
60CELC | CELCUITY INC | Healthcare | $4.31B | 0.29% |
61VKTX | VIKING THERAPEUTICS INC | Healthcare | $4.31B | 0.29% |
62EXLS | EXLSERVICE HOLDINGS INC | Technology | $4.30B | 0.29% |
63PII | POLARIS INC | Consumer Cyclical | $4.16B | 0.28% |
64PLNT | PLANET FITNESS INC | Consumer Cyclical | $4.16B | 0.28% |
65MARA | MARA HOLDINGS INC | Financial Services | $4.08B | 0.28% |
66DOCS | DOXIMITY INC | Healthcare | $3.94B | 0.27% |
67POWI | POWER INTEGRATIONS INC | Technology | $3.93B | 0.27% |
68WING | WINGSTOP INC | Consumer Cyclical | $3.88B | 0.26% |
69YETI | YETI HOLDINGS INC | Consumer Cyclical | $3.87B | 0.26% |
70RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.26% |
71LOPE | GRAND CANYON EDUCATION INC | Consumer Defensive | $3.72B | 0.25% |
72DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.70B | 0.25% |
73CCC | CCC INTELLIGENT SOLUTIONS HOLDINGS INC | Technology | $3.55B | 0.24% |
74AB | ALLIANCEBERNSTEIN HOLDING LP | Financial Services | $3.54B | 0.24% |
75LBTYA | LIBERTY GLOBAL LTD | Communication Services | $3.52B | 0.24% |
76CLSK | CLEANSPARK INC | Financial Services | $3.34B | 0.23% |
77ACHC | ACADIA HEALTHCARE COMPANY INC | Healthcare | $3.17B | 0.22% |
78UAA | UNDER ARMOUR INC | Consumer Cyclical | $3.17B | 0.22% |
79IDYA | IDEAYA BIOSCIENCES INC | Healthcare | $3.16B | 0.22% |
80CARG | CARGURUS INC | Consumer Cyclical | $3.16B | 0.22% |
81FSK | FS KKR CAPITAL CORP | Financial Services | $3.06B | 0.21% |
82EXPO | EXPONENT INC | Industrials | $3.05B | 0.21% |
83AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $3.02B | 0.21% |
84LUNR | INTUITIVE MACHINES INC | Industrials | $2.93B | 0.20% |
85RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $2.88B | 0.20% |
86LCID | LUCID GROUP INC | Consumer Cyclical | $2.87B | 0.20% |
87XRAY | DENTSPLY SIRONA INC | Healthcare | $2.81B | 0.19% |
88CLDX | CELLDEX THERAPEUTICS INC | Healthcare | $2.77B | 0.19% |
89GRND | GRINDR INC | Technology | $2.71B | 0.18% |
90NGVT | INGEVITY CORP | Basic Materials | $2.66B | 0.18% |
91RUM | RUMBLE INC | Technology | $2.51B | 0.17% |
92PBI | PITNEY BOWES INC | Industrials | $2.51B | 0.17% |
93TALO | TALOS ENERGY INC | Energy | $2.49B | 0.17% |
94ATRO | ASTRONICS CORP | Industrials | $2.41B | 0.16% |
95BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.16% |
96AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $2.36B | 0.16% |
97BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.16% |
98INTA | INTAPP INC | Technology | $2.24B | 0.15% |
99NOG | NORTHERN OIL & GAS INC | Energy | $2.24B | 0.15% |
100SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.15% |
101AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.15% |
102AIN | ALBANY INTERNATIONAL CORP | Consumer Cyclical | $2.12B | 0.14% |
103GT | GOODYEAR TIRE & RUBBER CO | Consumer Cyclical | $2.10B | 0.14% |
104CDNA | CAREDX INC | Healthcare | $2.05B | 0.14% |
105NUVB | NUVATION BIO INC | Healthcare | $2.03B | 0.14% |
106SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $2.02B | 0.14% |
107PLSE | PULSE BIOSCIENCES INC | Healthcare | $1.98B | 0.14% |
108URGN | UROGEN PHARMA LTD | Healthcare | $1.96B | 0.13% |
109GSHD | GOOSEHEAD INSURANCE INC | Financial Services | $1.93B | 0.13% |
110NGL | NGL ENERGY PARTNERS LP | Energy | $1.89B | 0.13% |
111WKC | WORLD KINECT CORP | Energy | $1.87B | 0.13% |
112MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | Healthcare | $1.87B | 0.13% |
113SAM | BOSTON BEER CO INC | Consumer Defensive | $1.86B | 0.13% |
114MQ | MARQETA INC | Technology | $1.85B | 0.13% |
115FUN | SIX FLAGS ENTERTAINMENT CORPORATION | Consumer Cyclical | $1.79B | 0.12% |
116NN | NEXTNAV INC | Technology | $1.78B | 0.12% |
117ASAN | ASANA INC | Technology | $1.77B | 0.12% |
118ZYME | ZYMEWORKS INC | Healthcare | $1.77B | 0.12% |
119BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.12% |
120FTRE | FORTREA HOLDINGS INC | Healthcare | $1.68B | 0.11% |
121VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.11% |
122NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.59B | 0.11% |
123ENOV | ENOVIS CORP | Industrials | $1.56B | 0.11% |
124CNXC | CONCENTRIX CORP | Technology | $1.49B | 0.10% |
125PRGO | PERRIGO CO PLC | Healthcare | $1.48B | 0.10% |
126MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.10% |
127YELP | YELP INC | Communication Services | $1.44B | 0.10% |
128ECVT | ECOVYST INC | Basic Materials | $1.41B | 0.10% |
129WBTN | WEBTOON ENTERTAINMENT INC | Technology | $1.41B | 0.10% |
130BRBR | BELLRING BRANDS INC | Consumer Defensive | $1.41B | 0.10% |
131FMC | FMC CORP | Basic Materials | $1.40B | 0.10% |
132AI | C3AI INC | Technology | $1.37B | 0.09% |
133CXM | SPRINKLR INC | Technology | $1.37B | 0.09% |
134DMLP | DORCHESTER MINERALS LP | Energy | $1.31B | 0.09% |
135HLIT | HARMONIC INC | Technology | $1.31B | 0.09% |
136XNCR | XENCOR INC | Healthcare | $1.30B | 0.09% |
137ABSI | ABSCI CORP | Healthcare | $1.29B | 0.09% |
138INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.28B | 0.09% |
139AMPL | AMPLITUDE INC | Technology | $1.27B | 0.09% |
140QDEL | QUIDELORTHO CORP | Healthcare | $1.19B | 0.08% |
141MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | $1.15B | 0.08% |
142SDGR | SCHRODINGER INC | Healthcare | $1.14B | 0.08% |
143EYPT | EYEPOINT INC | Healthcare | $1.12B | 0.08% |
144SECZ | SECURITIZE CORP | Technology | $1.11B | 0.08% |
145PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | $1.09B | 0.07% |
146PCT | PURECYCLE TECHNOLOGIES INC | Industrials | $1.09B | 0.07% |
147CGEM | CULLINAN THERAPEUTICS INC | Healthcare | $1.09B | 0.07% |
148NMAX | NEWSMAX INC | Communication Services | $1.08B | 0.07% |
149GRPN | GROUPON INC | Communication Services | $1.06B | 0.07% |
150AEVA | AEVA TECHNOLOGIES INC | Consumer Cyclical | $1.05B | 0.07% |
151AVTX | AVALO THERAPEUTICS INC | Healthcare | $1.02B | 0.07% |
152PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.01B | 0.07% |
153VOR | VOR BIOPHARMA INC | Healthcare | $980M | 0.07% |
154SMPL | SIMPLY GOOD FOODS CO | Consumer Defensive | $980M | 0.07% |
155KURA | KURA ONCOLOGY INC | Healthcare | $964M | 0.07% |
156ANNX | ANNEXON INC | Healthcare | $950M | 0.06% |
157AOSL | ALPHA & OMEGA SEMICONDUCTOR LTD | Technology | $936M | 0.06% |
158GO | GROCERY OUTLET HOLDING CORP | Consumer Defensive | $934M | 0.06% |
159WRLD | WORLD ACCEPTANCE CORP | Financial Services | $891M | 0.06% |
160REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.06% |
161NX | QUANEX BUILDING PRODUCTS CORP | Basic Materials | $835M | 0.06% |
162FOXF | FOX FACTORY HOLDING CORP | Consumer Cyclical | $798M | 0.05% |
163CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $777M | 0.05% |
164BBNX | BETA BIONICS INC | Healthcare | $771M | 0.05% |
165WEST | WESTROCK COFFEE CO | Consumer Defensive | $749M | 0.05% |
166IBTA | IBOTTA INC | Technology | $734M | 0.05% |
167CLYM | CLIMB BIO INC | Healthcare | $727M | 0.05% |
168AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.05% |
169CBLL | CERIBELL INC | Healthcare | $710M | 0.05% |
170SPRY | ARS PHARMACEUTICALS INC | Healthcare | $695M | 0.05% |
171NMFC | NEW MOUNTAIN FINANCE CORP | Financial Services | $672M | 0.05% |
172VTS | VITESSE ENERGY INC | Energy | $664M | 0.05% |
173CNNE | CANNAE HOLDINGS INC | Consumer Cyclical | $657M | 0.04% |
174HELE | HELEN OF TROY LTD | Consumer Defensive | $655M | 0.04% |
175EVH | EVOLENT HEALTH INC | Healthcare | $654M | 0.04% |
176KLC | KINDERCARE LEARNING COMPANIES INC | Consumer Defensive | $618M | 0.04% |
177TECX | TECTONIC THERAPEUTIC INC | Healthcare | $615M | 0.04% |
178FAC | FACTORIAL ENERGY INC | Industrials | $610M | 0.04% |
179NGNE | NEUROGENE INC | Healthcare | $590M | 0.04% |
180ALIT | ALIGHT INC | Technology | $584M | 0.04% |
181MYGN | MYRIAD GENETICS INC | Healthcare | $584M | 0.04% |
182IIIV | I3 VERTICALS INC | Technology | $579M | 0.04% |
183RYAM | RAYONIER ADVANCED MATERIALS INC | Basic Materials | $555M | 0.04% |
184EGY | VAALCO ENERGY INC | Energy | $553M | 0.04% |
185NPCE | NEUROPACE INC | Healthcare | $548M | 0.04% |
186YEXT | YEXT INC | Technology | $535M | 0.04% |
187TOI | ONCOLOGY INSTITUTE INC | Healthcare | $535M | 0.04% |
188TASK | TASKUS INC | Technology | $534M | 0.04% |
189KELYA | KELLY SERVICES INC | Industrials | $531M | 0.04% |
190ARVN | ARVINAS INC | Healthcare | $517M | 0.04% |
191DNA | GINKGO BIOWORKS HOLDINGS INC | Healthcare | $517M | 0.04% |
192RGNX | REGENXBIO INC | Healthcare | $511M | 0.03% |
193NVCT | NUVECTIS PHARMA INC | Healthcare | $508M | 0.03% |
194OIS | OIL STATES INTERNATIONAL INC | Energy | $507M | 0.03% |
195NRC | NRC HEALTH | Healthcare | $491M | 0.03% |
196SGMT | SAGIMET BIOSCIENCES INC | Healthcare | $479M | 0.03% |
197GTEN | GORES HOLDINGS X INC | Industrials | $472M | 0.03% |
198PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.03% |
199KYTX | KYVERNA THERAPEUTICS INC | Healthcare | $453M | 0.03% |
200STRZ | STARZ ENTERTAINMENT CORP | Communication Services | $450M | 0.03% |
201CCRN | CROSS COUNTRY HEALTHCARE INC | Healthcare | $428M | 0.03% |
202ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.03% |
203NPAC | NEW PROVIDENCE ACQUISITION CORP III | Industrials | $399M | 0.03% |
204STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.03% |
205WENN | WEN ACQUISITION CORP | Industrials | $387M | 0.03% |
206MGPI | MGP INGREDIENTS INC | Consumer Defensive | $382M | 0.03% |
207CVEO | CIVEO CORP | Industrials | $382M | 0.03% |
208UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.03% |
209EOLS | EVOLUS INC | Healthcare | $377M | 0.03% |
210CEPT | CANTOR EQUITY PARTNERS II INC | Industrials | $376M | 0.03% |
211ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.02% |
212SDHI | SIDDHI ACQUISITION CORP (CAYMAN ISLANDS) | Industrials | $364M | 0.02% |
213TACH | TITAN ACQUISITION CORP | Industrials | $360M | 0.02% |
214IPCX | INFLECTION POINT ACQUISITION CORP III | Industrials | $359M | 0.02% |
215SOUL | SOULPOWER ACQUISITION CORP | Industrials | $352M | 0.02% |
216SEG | SEAPORT ENTERTAINMENT GROUP INC | Real Estate | $332M | 0.02% |
217XRPN | ARMADA ACQUISITION CORP II | Industrials | $330M | 0.02% |
218RTAC | RENATUS TACTICAL ACQUISITION CORP I | Industrials | $329M | 0.02% |
219XPOF | XPONENTIAL FITNESS INC | Consumer Cyclical | $328M | 0.02% |
220VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.02% |
221OBA | OXLEY BRIDGE ACQUISITION LTD | Industrials | $325M | 0.02% |
222SZZL | SIZZLE ACQUISITION CORP II | Industrials | $325M | 0.02% |
223PESI | PERMA FIX ENVIRONMENTAL SERVICES INC | Industrials | $324M | 0.02% |
224TVA | TEXAS VENTURES ACQUISITION III CORP | Industrials | $316M | 0.02% |
225LYEL | LYELL IMMUNOPHARMA INC | Healthcare | $311M | 0.02% |
226PAMT | PAMT CORP | Industrials | $311M | 0.02% |
227PSBD | PALMER SQUARE CAPITAL BDC INC | Financial Services | $306M | 0.02% |
228ALCO | ALICO INC | Consumer Defensive | $304M | 0.02% |
229OPTX | SYNTEC OPTICS HOLDINGS INC | Technology | $302M | 0.02% |
230JENA | JENA ACQUISITION CORP II | Industrials | $301M | 0.02% |
231PACH | PIONEER ACQUISITION I CORP | Industrials | $293M | 0.02% |
232NXDT | NEXPOINT DIVERSIFIED REAL ESTATE TRUST | Real Estate | $291M | 0.02% |
233TKNO | ALPHA TEKNOVA INC | Healthcare | $291M | 0.02% |
234PAII | PYROPHYTE ACQUISITION CORP II | Industrials | $279M | 0.02% |
235MASS | 908 DEVICES INC | Healthcare | $278M | 0.02% |
236SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.02% |
237CEPO | CANTOR EQUITY PARTNERS I INC | Industrials | $271M | 0.02% |
238TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.02% |
239HCKT | HACKETT GROUP INC | Technology | $261M | 0.02% |
240SRZN | SURROZEN INC | Healthcare | $255M | 0.02% |
241LMNR | LIMONEIRA CO | Consumer Defensive | $245M | 0.02% |
242RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $243M | 0.02% |
243ARTV | ARTIVA BIOTHERAPEUTICS INC | Healthcare | $241M | 0.02% |
244MCGA | YORKVILLE ACQUISITION CORP | Industrials | $241M | 0.02% |
245GTE | GRAN TIERRA ENERGY INC | Energy | $233M | 0.02% |
246SMTI | SANARA MEDTECH INC | Healthcare | $229M | 0.02% |
247FC | FRANKLIN COVEY CO | Industrials | $229M | 0.02% |
248UP | WHEELS UP EXPERIENCE INC | Industrials | $229M | 0.02% |
249ONCH | 1RT ACQUISITION CORP | Industrials | $222M | 0.02% |
250KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.01% |
251KROS | KEROS THERAPEUTICS INC | Healthcare | $211M | 0.01% |
252FOCL | FOCAL INC | Healthcare | $204M | 0.01% |
253FORR | FORRESTER RESEARCH INC | Industrials | $200M | 0.01% |
254AMWL | AMERICAN WELL CORP | Healthcare | $199M | 0.01% |
255SRI | STONERIDGE INC | Consumer Cyclical | $197M | 0.01% |
256COOK | TRAEGER INC | Consumer Cyclical | $193M | 0.01% |
257EAF | GRAFTECH INTERNATIONAL LTD | Industrials | $181M | 0.01% |
258KRRO | KORRO BIO INC | Healthcare | $177M | 0.01% |
259ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.01% |
260NLOP | NET LEASE OFFICE PROPERTIES | Real Estate | $172M | 0.01% |
261MRDN | MERIDIAN HOLDINGS INC | Communication Services | $171M | 0.01% |
262KORE | KORE GROUP HOLDINGS INC | Communication Services | $163M | 0.01% |
263SPEG | SILVER PEGASUS ACQUISITION CORP | Industrials | $158M | 0.01% |
264RCEL | AVITA MEDICAL INC | Healthcare | $157M | 0.01% |
265EXOD | EXODUS MOVEMENT INC | Technology | $152M | 0.01% |
266HOFT | HOOKER FURNISHINGS CORP | Consumer Cyclical | $152M | 0.01% |
267CHPT | CHARGEPOINT HOLDINGS INC | Consumer Cyclical | $146M | 0.01% |
268DMRC | DIGIMARC CORP | Technology | $133M | 0.01% |
269OCC | OPTICAL CABLE CORP | Technology | $130M | 0.01% |
270FIRY | FIRY INC | Technology | $130M | 0.01% |
271AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.01% |
272INSG | INSEEGO CORP | Technology | $122M | 0.01% |
273SAMG | SILVERCREST ASSET MANAGEMENT GROUP INC | Financial Services | $118M | 0.01% |
274TCX | TUCOWS INC | Technology | $114M | 0.01% |
275STHO | STAR HOLDINGS | Real Estate | $114M | 0.01% |
276CPIX | CUMBERLAND PHARMACEUTICALS INC | Healthcare | $103M | 0.01% |
277CHRN | CHRONOSCALE CORP | Industrials | $94M | 0.01% |
278GEOS | GEOSPACE TECHNOLOGIES CORP | Energy | $88M | 0.01% |
279FVN | FUTURE VISION II ACQUISITION CORP | Industrials | $83M | 0.01% |
280AEYE | AUDIOEYE INC | Technology | $82M | 0.01% |
281BARK | BARK INC | Consumer Cyclical | $82M | 0.01% |
282PIII | P3 HEALTH PARTNERS INC | Healthcare | $78M | 0.01% |
283SEAT | VIVID SEATS INC | Communication Services | $78M | 0.01% |
284WTG | WINTERGREEN ACQUISITION CORP | Industrials | $76M | 0.01% |
285ACET | ADICET BIO INC | Healthcare | $76M | 0.01% |
286CLNN | CLENE INC | Healthcare | $76M | 0.01% |
287SCLX | SCILEX HOLDING CO | Healthcare | $72M | 0.00% |
288NDLS | NOODLES & CO | Consumer Cyclical | $66M | 0.00% |
289BGSF | BGSF INC | Industrials | $65M | 0.00% |
290BRID | BRIDGFORD FOODS CORP | Consumer Defensive | $59M | 0.00% |
291EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.00% |
292SKIL | SKILLSOFT CORP | Consumer Defensive | $58M | 0.00% |
293RIBB | RIBBON ACQUISITION CORP | Industrials | $54M | 0.00% |
294MCRB | SERES THERAPEUTICS INC | Healthcare | $52M | 0.00% |
295EXOZ | EXOZYMES INC | Healthcare | $51M | 0.00% |
296TIL | INSTIL BIO INC | Healthcare | $50M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $1.47T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 90% toward Large, 66% toward Growth. +15% unclassified (78 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual30.6%Margin-5.6%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 34.0% | 16.4% |
| 3 yearsp.a. | 21.2% | -7.3% |
| 5 yearsp.a. | 14.8% | 5.4% |
| 10 yearsp.a. | 16.4% | 3.3% |
| Since inceptionp.a. | 9.9% | 1.9% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 17.4% | 4.8% |
| 2025 | 17.2% | -5.9% |
| 2024 | 29.9% | -18.3% |
| 2023 | 31.1% | -9.8% |
| 2022 | -16.5% | 52.7% |
| 2021 | 19.5% | 32.4% |
| 2020 | 22.2% | -17.3% |
| 2019 | 27.3% | -1.5% |
| 2018 | -3.7% | 12.7% |
| 2017 | 22.6% | -6.2% |
| 2016 | 22.2% | 22.5% |
| 2015 | 0.7% | 1.0% |
| 2014 | 16.4% | 3.0% |
| 2013 | 39.4% | 7.8% |
| 2012 | 19.8% | -0.8% |
| 2011 | 7.3% | 6.7% |
| 2010 | 20.8% | -0.3% |
| 2009 | 36.7% | -19.1% |
| 2008 | -36.1% | 30.5% |
| 2007 | 5.9% | -14.8% |
| 2006 | 15.5% | 9.4% |
| 2005 | 0.9% | -6.3% |
| 2004 | -0.7% | -17.1% |
| 2003 | 45.7% | 2.1% |
| 2002 | -40.1% | -14.8% |
| 2001 | -14.0% | 34.9% |
| 2000 | -1.7% | 61.6% |
| 1999 | 29.8% | -37.0% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry DelEqu Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a DelEqu signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.